Europe · News · Reuters

EyePoint to cut workforce by half after experimental drug fails second late-stage trial

Published by Reuters · United Kingdom 8 h ago

EyePoint on Monday said it would cut about 53% of its workforce and stop studies of its experimental eye drug for ‌an age-related vision disease after it failed a second…

Read the full article on Reuters Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.reuters.com)

Also worth reading

Climate Home News

Istanbul flood death toll rises to eight as rescuers find more bodies, governor says

RTÉ

RTÉ calls editing out Palestinian flag necklace 'mistake'

Daily Mail

EyePoint to cut workforce by half after experimental drug fails second late-stage trial

Share

Also worth reading

IPCC scientists vow to press on with climate reports despite political deadlock

Stop ‘cash for trash’ housebuilding in Norfolk Broads, says Labour MP

Super sleuth cop catches burglar thanks to one-word clue

Istanbul flood death toll rises to eight as rescuers find more bodies, governor says

RTÉ calls editing out Palestinian flag necklace 'mistake'

Notorious Glasgow gangster Paul Ferris is laid to rest at the same crematorium as his gangland rival - following his sudden death at 62